Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

Taylor and Francis Group, HIV Clinical Trials, 2(17), p. 72-77, 2016

Journal article published in 2016 by Edgar Turner Overton, Pablo Tebas

, Bruce Coate, Robert Ryan, Amy Perniciaro, Yaswant K. Dayaram, Guy De La Rosa, Bryan P. Baugh

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by